Abstract
Objective: To investigate the effect of overexpression of Bax to the sensitivity of human HCC-9204 cells to adriamycin (ADR). Methods: Human cultured hepatocellular carcinoma cell line HCC-9204 was exposed in vitro to adriamycin for various time. An inducible vector containing Bax gene, with ZnSO4 as external inducer was constructed. Cell apoptosis was ascertained by morphological criteria, detection of apoptotic DNA fragmentation by TUNEL assay and flow cytometry. Tetrazolium blue (MTT) assay was used to evaluate the differences in drug sensitivity of HCC-9204 cells after Bax-transfection. Results: HCC-9204 cells treated with adriamycin at 20 µ mol/L showed extensive cell death. TUNEL assay showed nucleus fragmentation. And apoptotic peak was also shown by flow cytometry. FACS analyses showed a significant sub-G1 peak and apoptosis in 31% cells at 24h after treatment. Furthermore, the time-course of cell viability following exposure of HCC-9204/Bax cells to adriamycin showed that Bax was able to significantly decrease cell survival following exposure to adriamycin. Conclusion: These results indicate that apoptosis can be induced effectively by adriamycin and overexpression of Bax can sensitize HCC-9204 cells to apoptosis induced by adriamycin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Strobel T, Swanson L, Korsmeyer S, et al. Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway [J]. Proc Natl Acad Sci USA 1996; 93:14094–9.
Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents [J]. Cancer Res 1999; 59:1391–9.
Kobayashi T, Ruan S, Clodi K, et al. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents [J]. Oncogene 1998; 16:1587–91.
Guo B, Cao S, Toth K, et al. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma [J]. Clin Cancer Res 2000; 6:718–24.
Gamen S, Anel A, Perez-Galan P, et al. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells [J]. Exp Cell Res 2000; 258:223–35.
Panaretakis T, Pokrovskaja K, Shoshan MC, et al. Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin [J]. J Biol Chem 2002; 277:44317–26.
LeBlanc H, Lawrence D, Varfolomeev E, et al. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax [J]. Nat Med 2002; 8:274–81.
Leung LK, Wang TT. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7 [J]. Breast Cancer Res Treat 1999; 55:73–83.
Kobayashi T, Sawa H, Morikawa J, et al. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells [J]. Jpn J Cancer Res 2000; 91:1264–8.
Komarova EA, Chernov MV, Franks R, et al. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo [J]. EMBO J 1997; 6:1391–400.
Author information
Authors and Affiliations
Corresponding author
Additional information
Biography: ZHENG Jian-yong (1968–), male, doctor of medicine, Fourth Military Medical University, majors in experimental gene therapy of gastrointestinal cancer.
Rights and permissions
About this article
Cite this article
Zheng, Jy., Li, J., Li, Kz. et al. Bax overexpression enhances apoptosis induced by adriamycin in HCC-9204 cells. Chin. J. Cancer Res. 16, 157–161 (2004). https://doi.org/10.1007/s11670-004-0018-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-004-0018-6